145P Tislelizumab (TIS) + chemotherapy (Chemo)/chemoradiotherapy (CRT) as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (R-ESCC)

L. Chen,Y. Liao, T. Jiang, M. Kang, X. Mei, L. Tan, J. Liu, Z. Zhang, W. Yu, L. Li,H. Jiang

Annals of Oncology（2023）

引用 0|浏览5